Positive news for people who have tested positive for COVID-19.

Join a study now testing an oral medication for unvaccinated patients.

Positive news for people who have tested positive for COVID-19.

Join a study now testing an oral medication for unvaccinated patients.

Positive news for people who have tested positive for COVID-19.

Join a study now testing an oral medication for unvaccinated patients.

You tested positive for SARS-CoV-2, the virus that causes COVID-19. You may be having symptoms like fever, aches, and cough. You’re at home now, and the last thing you want is to end up in the hospital.

Join our clinical study testing an investigational drug called Tempol. It’s a unique medication – a powerful antiviral, anti-inflammatory, antioxidant medicine.

We’re looking for people with certain conditions–like obesity, high blood pressure, and diabetes–to see if study treatment can keep you from developing severe illness requiring hospitalization and to see how long it takes to relieve your symptoms.

Please contact a local study site to learn more. If you want to take part in the study, you must act fast and join within 5 days of receiving a positive COVID-19 lab test.

To qualify for the study, you must:

  • Have a laboratory confirmed infection of SARS-CoV-2 within the last 5 days
  • Have at least moderate severity of at least two COVID-19 symptoms (e.g., stuffy or runny nose, sore throat, fever, chills or shivers, difficulty breathing, coughing, headache, tiredness, muscle aches and pains, or nausea)
  • Be 18 years of age or older with at least one existing condition (hypertension, diabetes, obesity, cancer, chronic renal disease, or immunodeficiency)
  • Be able to travel to a clinic and be able to swallow a capsule
  • Not have had a COVID-19 vaccine
  • Not have previously had another documented COVID-19 infection

ABOUT THE STUDY.

Your participation is a vital part of finding potential new treatments for COVID-19. The goal of the study is to help patients like you and others avoid being hospitalized. We really appreciate your involvement.

Watch

Our Video

ABOUT THE STUDY DRUG.

Tempol is a novel antioxidant and anti-inflammatory medication that has been shown to attenuate Acute Respiratory Distress Syndrome (ARDS) in the lungs and decrease associated inflammatory cytokines (cytokine storm). ARDS is a serious consequence of COVID-19 that can be difficult to treat, even with mechanical ventilation. Tempol was originally studied by the National Cancer Institute as a drug to provide protection to certain body organs during radiation therapy for cancer. It has also been studied extensively in animals. Because of Tempol’s mechanism of action, it may also prevent viral replication of the COVID-19 virus, regardless of the variant.

Anti-Inflammatory

Antioxidant

Antiviral

ABOUT CLINICAL STUDIES.

A clinical study (or “clinical trial”) is designed to evaluate how safe and/or effective an investigational drug is in treating a specific disease or condition. An investigational drug is a substance that has been tested in the laboratory and has not been approved by the United States Food and Drug Administration (FDA). The FDA uses the results of clinical studies to decide if an investigational drug should be made available to patients. Clinical studies are the only way we can develop new and better treatments and improve patient care.

Clinical studies are conducted by experienced and trained medical professionals who monitor the health of participants throughout the study. Additionally, every clinical study is reviewed by an Institutional Review Board (IRB), which helps ensure that the study is conducted safely and that the rights of study participants are protected.